Literature DB >> 26047065

Focal epithelial hyperplasia by human papillomavirus (HPV)-32 misdiagnosed as HPV-16 and treated with combination of retinoids, imiquimod and quadrivalent HPV vaccine.

Franco Gemigniani1, Javier Hernández-Losa2, Berta Ferrer2, Vicente García-Patos1.   

Abstract

Focal epithelial hyperplasia (FEH) or Heck's disease is a rare, benign and asymptomatic mucosal proliferation associated with human papillomavirus (HPV) infection, mainly with genotypes 13 and 32. We report a florid case of FEH in an 11-year-old Haitian girl with systemic lupus erythematosus receiving immunosuppressive therapy. Cryotherapy was previously performed on numerous occasions with no results. We decided to prescribe a non-invasive and more comfortable treatment. A combination of topical retinoid and imiquimod cream was well tolerated and led to an important improvement. The evidence of infection by HPV-16 detected by polymerase chain reaction (PCR) technique, prompted us to prescribe the quadrivalent HPV vaccine (types 6, 11,16 and 18). Subsequent PCR sequencing with generic primers GP5-GP6 and further BLAST comparative analysis confirmed that genomic viral sequence in our case truly corresponded with HPV-32. This molecular misdiagnosis can be explained by the similarity between genomic sequences of both HPV-16 and -32 genotypes. At the 1-year follow up, we observed total clinical improvement and no recurrences of the disease. Complete healing in this case may correspond to a potential action of topical retinoid, imiquimod and the cross-protection mechanism of the quadrivalent HPV vaccine.
© 2015 Japanese Dermatological Association.

Entities:  

Keywords:  focal epithelial hyperplasia; human papillomavirus; imiquimod; polymerase chain reaction; quadrivalent human papillomavirus vaccine

Mesh:

Substances:

Year:  2015        PMID: 26047065     DOI: 10.1111/1346-8138.12967

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  Unusual presentation of a disseminated oral HPV infection after combined antiretroviral therapy initiation.

Authors:  Daniela Assis do Vale; Lais Magda Araújo Ferracini; Marcus Vinícius da Silva Rodrigues Bueno; Ana Carolina Mamana Fernandes Souza; Paulo Henrique Braz-Silva; Karem López Ortega
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-10-10       Impact factor: 1.846

2.  Exuberant oral lesions in an immunocompromised patient.

Authors:  Cleide Garbelini Lima Forneck; Gabriela Evangelista de Almeida; Marcela Carolina Pastore; Andréa de Souza Cavalcante; Mara Lúcia Gomes de Souza
Journal:  JAAD Case Rep       Date:  2020-12-05

3.  Oral florid papillomatosis: Topical treatment with 5% imiquimod in orabase.

Authors:  Pedro Ruiz-Huertas; Alicia Borrego-Luque; Pilar Toledano-Valero; Carolina Manzotti; Ángel Rollón-Mayordomo
Journal:  Clin Exp Dent Res       Date:  2022-04-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.